Skip to main content
TipRanks
Go Ultimate75% OFF

Innovent Biologics (6IB) Q4 2024 Earnings Report

4 Followers

DE:6IB Q4 2024 EPS Results

Actual EPS
EUR 0.02
Consensus EPS
-EUR 0.03
Beat/Miss
Beat by +EUR 0.06
One Year Ago EPS
-EUR 0.08

DE:6IB Q4 2024 Revenue Results

Actual Revenue
EUR 677.91M
Expected Revenue
EUR 625.46M
Beat/Miss
Beat by +EUR 52.45M
YoY Revenue Growth
+56.72%

Earnings Announcement Details

Quarter
Q4 2024
Date
03/26/2025
Time
Before Open
Conference Call
Wednesday, March 26, 2025
DE:6IB Upcoming Earnings

Innovent Biologics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Q4 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2024 Earnings Slide Deck

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:6IB Earnings History

DE:6IB earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 31, 20272026 (Q4)0.15-0――
Aug 25, 20262026 (Q2)0.060.090.0737.25% (+0.03)
Mar 26, 20262025 (Q4)0.02-0.000.02-105.56% (-0.03)
Aug 27, 20252025 (Q2)0.020.07-0.03312.50% (+0.10)
Mar 26, 20252024 (Q4)-0.030.02-0.08131.69% (+0.10)
Aug 28, 20242024 (Q2)-0.03-0.03-0.01-166.67% (-0.02)
Mar 20, 20242023 (Q4)-0.09-0.08-0.1132.38% (+0.04)
Aug 23, 20232023 (Q2)-0.09-0.01-0.0986.15% (+0.08)
Mar 31, 20232022 (Q4)-0.09-0.11-0.1837.78% (+0.07)
Aug 25, 20222022 (Q2)-0.91-0.09-0.1119.75% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed